INDP Indaptus Therapeutics Inc
Company Analysis
Latest News
🔴 Indaptus Therapeutics is trading 10.64% down today amid stock-specific volatility and weaker U.S. indexes
Indaptus Therapeutics is trading at $3.57, down 10.64%, amid continued stock-specific volatility and weaker major U.S. indexes. - No new company-specific...
🔴 Indaptus Therapeutics is trading 6.77% down today with no new company-specific catalyst identified
Indaptus Therapeutics is trading 6.77% down at $3.72 amid stock-specific volatility, with no new company-specific announcement or direct catalyst identified...
🟢 Indaptus Therapeutics is trading 6.52% up in pre-market amid broader biotech strength
Indaptus Therapeutics is trading 6.52% higher at $4.25, after closing September 22, 2026 at $3.99, with broader biotechnology-sector strength supporting...
🟢 Indaptus Therapeutics is trading 10.19% up today — no clear catalyst identified
Indaptus Therapeutics is trading at $3.40, up 10.19%, with the rally’s precise reason unclear. - It rebounded from the September 21, 2026 close of $3.09 after...
🔴 Indaptus Therapeutics is trading 10% down today after opening-market selling
Indaptus Therapeutics is trading 10% down at $3.19 after opening-market selling, with no clear company-specific announcement identified for September 21,...
🔴 Indaptus Therapeutics is trading 5.41% down today with no clear company-specific announcement
Indaptus Therapeutics is trading 5.41% down at $3.36, with no clear company-specific announcement explaining the September 21 decline. - It follows a close of...
🟢 Indaptus Therapeutics is trading 5.6% up in pre-market with no clear company-specific catalyst
Indaptus Therapeutics is trading at $3.75, up 5.63%, with no fresh company-specific announcement identified to explain the move. • The stock closed at $3.55...
🟢 Indaptus Therapeutics is trading 5% up today in after-hours trading with no clear company-specific catalyst
Indaptus Therapeutics is trading 5.07% up now at $3.73 after its September 18, 2026, close at $3.55, down 9.67%; no fresh company-specific announcement...
🔴 Indaptus Therapeutics is trading 5.1% down today, reversing part of September 17 advance
Indaptus Therapeutics is trading 5.1% down at $3.73, with no fresh company-specific announcement clearly explaining the September 18 decline. - The move...
🟢 Indaptus Therapeutics is trading 10.59% up today as biotechnology shares rebound
Indaptus Therapeutics is trading 10.59% up now at $3.55 as biotechnology shares rebound alongside a stronger broader market. - The biotech sector is...
🟢 Indaptus Therapeutics is trading 7.17% up today as biotechnology shares rebound
Indaptus Therapeutics is trading 7.17% up at $3.45 as biotechnology shares rebound and broader risk sentiment improves on September 17, 2026. - The sector is...
🔴 Indaptus Therapeutics is trading 10.16% down today as biotech sector declines
Indaptus Therapeutics is trading 10.16% down at $3.27 as biotech sentiment deteriorates, with XBI declining 2.11% during regular trading. - The decline...
🔴 Indaptus Therapeutics is trading 6.5% down today as biotech ETF XBI falls
Indaptus Therapeutics is trading 6.5% down now at $3.40, with the decline appearing primarily sector-driven. - Biotech ETF XBI was down 2.11% during regular...
🟢 Indaptus Therapeutics is trading 12.74% up today after a $24 million private placement
Indaptus Therapeutics is trading 12.74% up at $3.54 as investors continue responding to its September 10 announcement of an approximately $24 million private...
🟢 Indaptus Therapeutics is trading 6.37% up today after $24 million private placement
Indaptus Therapeutics is trading $3.34 (+6.37%) after continued investor response to its September 10 announcement of a private placement raising approximately...
🟢 Indaptus Therapeutics is trading 10.4% up today after a roughly $24 million private placement
Indaptus Therapeutics is trading 10.43% up now at $3.06 as investors continue responding to the September 10 private-placement announcement. • Financing...
🟢 Indaptus Therapeutics is trading 7.57% up today after a roughly $24 million private placement
Indaptus Therapeutics is trading at $2.98 (+7.57%) as investors continue responding to the company’s September 10 private-placement announcement. • Financing...
🟢 Indaptus Therapeutics is trading 12.57% up today after announcing a roughly $24 million private placement
Indaptus Therapeutics is trading 12.57% up now at $2.88 after announcing a roughly $24 million private placement on September 10, 2026. - The financing covers...
🟢 Indaptus Therapeutics is trading 8.6% up today after announcing a roughly $24 million private placement
Indaptus Therapeutics is trading 8.6% up now at $2.78 after its September 10, 2026 announcement of a roughly $24 million private placement. - The financing...
🟢 Indaptus Therapeutics is trading 5.9% up in pre-market after announcing $24 million private placement
Indaptus Therapeutics is trading 5.9% up now at $2.71 after announcing a roughly $24 million private placement of approximately 20.3 million shares on...